Rahul Iyer

Australia's squad for the first Ashes Test reflected the ageing nature of their red-ball team; which players could be next up?

Between the first and second Tests against South Africa, India released and recalled all-rounder Nitish Kumar Reddy from the A team. But the entire exercise had little benefit, writes Rahul Iyer.

The latest twist in Shakib Al Hasan's career came on Sunday, when he declared that he was "officially not retired" from all formats. Read more here.

Since the inception of the World Test Championship in 2019, which have been the most lopsided bowler-batter face-offs across the competition’s history?

The player auction ahead of the 2026 IPL will take place next week; which domestic performers stand a good chance of commanding a hefty price?

With the T20 World Cup arriving in February, South Africa's top three for the tournament remains a mystery.

Despite advancements in prandial insulin therapeutics, real-world usage of these products is associated with challenges such as injection-related anxiety, an increased risk of hypoglycemia, and weight gain. Other factors contributing to insulin non-adherence include travel-related storage issues, public embarrassment related to administration, and busy schedules. In India, where postprandial hyperglycemia remains a concern, there is a need for effective and patient-friendly strategies to manage glycemia adequately. Afrezza® (MannKind Corporation, Danbury, CT, USA), an inhaled Technosphere® insulin, provides a non-invasive, needle-free approach that has a rapid onset of action and short duration of action and has been demonstrated to closely mimic the physiological insulin profile. Afrezza® is a dry powder recombinant human insulin formulation adsorbed onto a proprietary carrier, developed for the delivery of insulin deep into the alveoli of the lungs, where it is absorbed into the systemic circulation. This review seeks to clarify the clinical role of inhaled insulin by addressing common myths associated with its usage and presenting evidence-based insights on its pharmacokinetic (PK) and pharmacodynamic (PD) profile, efficacy and safety, pulmonary safety, dosing considerations, storage requirements, use in special populations, and contraindications. The review also discusses practical aspects of Afrezza® use, especially proper patient screening based on spirometry testing, patient education, and counseling. Ultimately, Afrezza® signifies a transformation in insulin therapy, offering an effective and convenient alternative to prandial insulin for adult patients with type 1 diabetes mellitus (T1DM) or type 2 diabetes mellitus (T2DM).

Rahul Iyer MCG Boxing Day pitch rated 'Unsatisfactory' The fourth Test of the ongoing Ashes series ended in under two days, as England won

Traders started calling copper “Doctor Copper” sometime in the 1980s. The nickname stuck because it kept being right. When copper climbed, economic activity typically followed. When it fell, the slowdown was usually not far behind. For a metal that has no financial market drama attached to it – no central bank policy, no OPEC-style cartel, no geopolitical premium baked in by default – copper has an unusually reliable record of telling the truth about what is happening in the real economy before the data confirms it.

Which are the highest totals to be successfully chased down in an IPL final?